Prescription Drug Monitoring Program Use and Utility by Washington State Pharmacists: A Mixed Methods Study

Journal of the American Pharmacists Association

Fecha de publicación: 5 October 2019

DOI: https://doi.org/10.1016/j.xphs.2019.09.023

Autores: Tapan K. Das, Linda O. Narhi, Alavattam Sreedhara, Tim Menzen, Christoph Grapentin, Danny K. Chou, Valentyn Antochshuk, Vasco Filipe.

Background: The success of biotherapeutic development heavily relies on establishing robust production platforms. During the manufacturing process, the protein is exposed to multiple stress conditions that can result in physical and chemical modifications. The modified proteins may raise safety and quality concerns depending on the nature of the modification.